Ani Pharmaceuticals Inc SEC filings ANIP
Ani Pharmaceuticals Inc has 1,003 filings in SEC EDGAR's recent list, going back to Nov 3, 2014. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, new debt, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| CT ORDER | Filing | Feb 22, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| CORRESP | Letter to the SEC | Jan 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2022 | — |
| CORRESP | Letter to the SEC | Dec 5, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2022 | — |
| EFFECT | Filing | Jan 18, 2022 | — |
| CORRESP | Letter to the SEC | Jan 13, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2021 | — |
| EFFECT | Filing | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2020 | — |
| CT ORDER | Filing | May 15, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| CT ORDER | Filing | Apr 2, 2020 | — |
| CT ORDER | Filing | Apr 2, 2020 | — |
| CT ORDER | Filing | Jul 1, 2019 | — |
| CT ORDER | Filing | Mar 18, 2019 | — |
| CT ORDER | Filing | Feb 22, 2019 | — |
| CT ORDER | Filing | Feb 22, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2018 | — |
| CORRESP | Letter to the SEC | Oct 31, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2018 | — |
| CORRESP | Letter to the SEC | Sep 18, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| CT ORDER | Filing | Apr 5, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2017 | — |
| CORRESP | Letter to the SEC | Oct 20, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2017 | — |
| CORRESP | Letter to the SEC | Sep 29, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2017 | — |
| EFFECT | Filing | Jul 11, 2017 | — |
| CORRESP | Letter to the SEC | Jul 7, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2017 | — |
| CT ORDER | Filing | Jun 7, 2017 | — |
| CT ORDER | Filing | May 19, 2017 | — |
| CT ORDER | Filing | Aug 9, 2016 | — |
| CT ORDER | Filing | Mar 14, 2016 | — |
| CT ORDER | Filing | Feb 1, 2016 | — |
| CT ORDER | Filing | Sep 22, 2015 | — |
| CT ORDER | Filing | Jun 22, 2015 | — |
| EFFECT | Filing | Feb 23, 2015 | — |
| CT ORDER | Filing | Feb 4, 2015 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANIP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1023024
- Former names
- BIOSANTE PHARMACEUTICALS INC (until Jul 18, 2013); BEN ABRAHAM TECHNOLOGIES INC (until Dec 23, 1999)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.